A pill to treat COVID-19 patients can now be distributed throughout Paraguay's conventional pharmaceutical network after two local laboratories were granted a registration license to manufacture Molnupiravir, the pill developed by Merck.
World Health Organization (WHO) partners Unitaid have announced an agreement with the Pfizer laboratories to manufacture generic oral drugs to be used against COVID-19.
The United Kingdom Thursday became the first country in the world to authorize the use of molnupiravir, a pill developed by US laboratories Merck, to treat COVID-19.